• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The origin of the very variable haemolytic activities of the common human complement component C4 allotypes including C4-A6.

作者信息

Dodds A W, Law S K, Porter R R

出版信息

EMBO J. 1985 Sep;4(9):2239-44. doi: 10.1002/j.1460-2075.1985.tb03920.x.

DOI:10.1002/j.1460-2075.1985.tb03920.x
PMID:3852741
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC554491/
Abstract

The human complement component C4 occurs in many different forms which show big differences in their haemolytic activities. This phenomenon seems likely to be of considerable importance both physiologically and pathologically. C4 is coded by duplicated genes between HLA-D and HLA-B loci in the major histocompatibility complex in man. Several fold differences in haemolytic activity between products of the two loci C4-A and C4-B have been correlated with changes of six amino acid residues in this large protein of 1722 residues and with differences of several fold in the covalent binding of C4 to antibody-antigen aggregates. Some allotypes of one locus also differ markedly, notably C4-A6 which has 1/10th the haemolytic activity of other C4-A allotypes. A monoclonal antibody affinity column has been prepared which is able to separate C4-A from C4-B proteins and, using serum from an individual expressing only the C4-A6 allele at the C4-A locus, C4-A6 protein has been prepared. Investigation has shown C4-A6 to have the same reactivity as other C4-A allotypes except in the formation of the complex protease, C5 convertase. This protease is formed from C4, C2 and C3 and if C4-A6 is used it has approximately 1/5th the catalytic activity compared with other C4-A allotype. Allelic differences in sequence identified in C4 proteins so far are few and it is probable that the big difference in catalytic activity of C5 convertase is caused by very small changes in structure.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe07/554491/7e2462f0dc86/emboj00274-0095-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe07/554491/0058031138ef/emboj00274-0094-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe07/554491/7e2462f0dc86/emboj00274-0095-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe07/554491/0058031138ef/emboj00274-0094-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe07/554491/7e2462f0dc86/emboj00274-0095-a.jpg

相似文献

1
The origin of the very variable haemolytic activities of the common human complement component C4 allotypes including C4-A6.
EMBO J. 1985 Sep;4(9):2239-44. doi: 10.1002/j.1460-2075.1985.tb03920.x.
2
The low C5 convertase activity of the C4A6 allotype of human complement component C4.人类补体成分C4的C4A6同种异型的低C5转化酶活性。
Biochem J. 1989 Aug 1;261(3):743-8. doi: 10.1042/bj2610743.
3
The purification and properties of some less common allotypes of the fourth component of human complement.人类补体第四成分某些较不常见同种异型的纯化及特性
Immunogenetics. 1986;24(5):279-85. doi: 10.1007/BF00395532.
4
Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.C4结合蛋白在系统性红斑狼疮患者经典途径C3转化酶调节中的相对重要性
Clin Exp Immunol. 1983 Oct;54(1):248-52.
5
Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator.血浆蛋白C4结合蛋白和C3b灭活剂对经典途径C3转化酶的调节作用。
Proc Natl Acad Sci U S A. 1979 Dec;76(12):6596-600. doi: 10.1073/pnas.76.12.6596.
6
The effect of null C4 alleles on complement function.
Clin Immunol Immunopathol. 1985 Mar;34(3):316-25. doi: 10.1016/0090-1229(85)90180-1.
7
The molecular genetics of components of complement.补体成分的分子遗传学
Adv Immunol. 1986;38:203-44. doi: 10.1016/s0065-2776(08)60007-3.
8
A model system for the study of the assembly and regulation of human complement C3 convertase (classical pathway).用于研究人类补体C3转化酶(经典途径)组装与调节的模型系统。
Eur J Immunol. 1986 Jun;16(6):617-22. doi: 10.1002/eji.1830160606.
9
Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.经典途径激活的表面调节:绵羊、豚鼠和人红细胞上C2和C3转化酶的形成与调节
J Immunol. 1983 Jul;131(1):403-8.
10
Relationship between the component and regulatory proteins of the classical pathway C3 convertase.经典途径C3转化酶的组成蛋白与调节蛋白之间的关系。
J Lab Clin Med. 1986 Jun;107(6):529-33.

引用本文的文献

1
Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans.人类系统性红斑狼疮(SLE)中补体成分C4的基因拷贝数变异及相关多态性:在欧裔美国人中,低拷贝数是SLE易感性的危险因素,而高拷贝数是SLE易感性的保护因素。
Am J Hum Genet. 2007 Jun;80(6):1037-54. doi: 10.1086/518257. Epub 2007 Apr 26.
2
The internal thioester and the covalent binding properties of the complement proteins C3 and C4.补体蛋白C3和C4的内部硫酯及共价结合特性。
Protein Sci. 1997 Feb;6(2):263-74. doi: 10.1002/pro.5560060201.
3

本文引用的文献

1
Different HLA antigen associations for the functionally active and inactive products of the complement C4F1 allele.补体C4F1等位基因的功能活性和非活性产物存在不同的HLA抗原关联。
Hum Immunol. 1980 Jul;1(1):23-30. doi: 10.1016/0198-8859(80)90006-3.
2
Purification of human C3b inactivator by monoclonal-antibody affinity chromatography.用单克隆抗体亲和层析法纯化人C3b灭活剂。
Biochem J. 1982 Apr 1;203(1):293-8. doi: 10.1042/bj2030293.
3
Human C4-binding protein: N-terminal amino acid sequence analysis and limited proteolysis by trypsin.
Effect of thiol compounds on human complement component C4.
硫醇化合物对人补体成分C4的影响。
Biochem J. 1993 Feb 1;289 ( Pt 3)(Pt 3):801-5. doi: 10.1042/bj2890801.
4
The thioester and isotypic sites of complement component C4 in sheep and cattle.绵羊和牛体内补体成分C4的硫酯位点和同型位点。
Immunogenetics. 1993;37(2):120-8. doi: 10.1007/BF00216835.
5
Heat shock and the heat shock proteins.热休克与热休克蛋白
Biochem J. 1986 Dec 1;240(2):313-24. doi: 10.1042/bj2400313.
6
Polymorphism of the human complement C4 and steroid 21-hydroxylase genes. Restriction fragment length polymorphisms revealing structural deletions, homoduplications, and size variants.人类补体C4和类固醇21-羟化酶基因的多态性。揭示结构缺失、同型重复和大小变异的限制性片段长度多态性。
J Clin Invest. 1986 Sep;78(3):650-7. doi: 10.1172/JCI112623.
7
The low C5 convertase activity of the C4A6 allotype of human complement component C4.人类补体成分C4的C4A6同种异型的低C5转化酶活性。
Biochem J. 1989 Aug 1;261(3):743-8. doi: 10.1042/bj2610743.
8
Inhibition of the covalent binding reaction of complement component C4 by penicillamine, an anti-rheumatic agent.抗风湿药青霉胺对补体成分C4共价结合反应的抑制作用。
Biochem J. 1989 Apr 15;259(2):415-9. doi: 10.1042/bj2590415.
9
A structural model for the location of the Rodgers and the Chido antigenic determinants and their correlation with the human complement component C4A/C4B isotypes.罗杰斯和奇多抗原决定簇定位及其与人类补体成分C4A/C4B同种型相关性的结构模型。
Immunogenetics. 1988;27(6):399-405. doi: 10.1007/BF00364425.
10
The purification and properties of some less common allotypes of the fourth component of human complement.人类补体第四成分某些较不常见同种异型的纯化及特性
Immunogenetics. 1986;24(5):279-85. doi: 10.1007/BF00395532.
FEBS Lett. 1982 Jan 11;137(1):75-9. doi: 10.1016/0014-5793(82)80318-9.
4
The proteolytic activation systems of complement.补体的蛋白水解激活系统。
Annu Rev Biochem. 1981;50:433-64. doi: 10.1146/annurev.bi.50.070181.002245.
5
A haemolytically non-active C4 gene product.一种无溶血活性的C4基因产物。
Immunobiology. 1980;158(1-2):91-5. doi: 10.1016/s0171-2985(80)80046-5.
6
Covalent binding and hemolytic activity of complement proteins.补体蛋白的共价结合与溶血活性
Proc Natl Acad Sci U S A. 1980 Dec;77(12):7194-8. doi: 10.1073/pnas.77.12.7194.
7
Statement on the nomenclature of human C4 allotypes.关于人类C4同种异型命名的声明。
Immunobiology. 1983 Mar;164(2):184-91. doi: 10.1016/s0171-2985(83)80009-6.
8
Large scale isolation of functionally active components of the human complement system.大规模分离人补体系统的功能活性成分。
J Biol Chem. 1981 Apr 25;256(8):3995-4006.
9
Complement polymorphism, the major histocompatibility complex and associated diseases: a speculation.补体多态性、主要组织相容性复合体及相关疾病:一种推测
Mol Biol Med. 1983 Jul;1(1):161-8.
10
The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4.人类补体成分C4的Chido和Rodgers同种型免疫溶血活性差异的分子基础。
J Immunol. 1984 Jun;132(6):3019-27.